# BES, EES, and ZES-R in Real World Practice

Study · id `cardio:ct-nct01397175` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01397175](<https://clinicaltrials.gov/study/NCT01397175>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01397175

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1960 participants.

## Technical summary

Registry record NCT01397175. Randomized; single masking; primary purpose treatment. Start 2013-01-16 (actual); primary completion 2017-12-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 1960 participants (enrolled count; ClinicalTrials.gov record NCT01397175, source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)
- Started: 2013-01-16 (actual) (ClinicalTrials.gov record NCT01397175, source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)
- Primary completion: 2017-12-05 (actual) (ClinicalTrials.gov record NCT01397175, source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)
- Completion: 2019-01-01 (actual) (ClinicalTrials.gov record NCT01397175, source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)
- Countries: South Korea (ClinicalTrials.gov record NCT01397175, source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01397175-2019-07-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: BES, EES, and ZES-R in Real World Practice
- Acronym: CHOICE
- Condition: Coronary Artery Disease
- Intervention (Device): Biolimus-eluting stent
- Intervention (Device): Everolimus-eluting stent
- Intervention (Device): Zotarolimus-eluting stent
- Lead sponsor: Yonsei University
- Lead sponsor class: OTHER
- Collaborator: Gangwon Cardiovascular Health Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Yonsei University (`cardio:org-yonsei-university`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Randomized Comparison of Everolimus- and Zotarolimus-Eluting Coronary Stents With Biolimus-Eluting Stents in All-Comer Patients (`cardio:pubmed-32160779`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: bcdbe78659cca5271b1d7021e73ae2e27fa9fbe17cc3feca448478202a11613b
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
